The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1360
March 21, 2011
View Complete Issue         Table of Contents 2019 
NitroMist Nitroglycerin Spray for Angina
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
NitroMist Nitroglycerin Spray for Angina
March 21, 2011 (Issue: 1360)
The FDA has approved a lingual aerosol formulation of nitroglycerin (NitroMist – Akrimax) for acute relief of an attack or acute prophylaxis of angina pectoris. It is the second nitroglycerin lingual spray to become available in the US;...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: NitroMist Nitroglycerin Spray for Angina
Article code: 1360b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.